Key result
Pulmonary hypertension affects ~44% of CKD patients at baseline and increases at six months.
Why the study?
What is the prevalence and what are the risk factors for pulmonary hypertension in patients with chronic kidney disease?
Observational (n=108)
No
What is the prevalence and what are the risk factors for pulmonary hypertension in patients with chronic kidney disease?
Pulmonary hypertension is highly prevalent (43.5%-50%) in patients with chronic kidney disease and is driven by factors such as fluid retention, anemia, and left-sided heart failure.
PH common in CKD may warrant screening; leaves open whether modifying risks alters outcomes.
< 0.01). Mean interdialytic weight gain and central venous pressure were higher among PH group than non-PH group. Higher calcium phosphate product ≥50 was more prevalent in PH group than in non-PH group. The majority of them had moderate PH at the beginning of the study which remained same, despite being on hemodialysis. PH is a common complication in CKD patients with prevalence of 43.5%-50%. Left-sided heart failure, anemia, fluid retention, and increased calcium phosphate product are the risk factors for developing PH.
No takes yet. Share an insight, caveat, or question.
Suresh et al. (2017) conducted an observational in Chronic kidney disease (n=108). Chronic kidney disease was evaluated on Prevalence of pulmonary hypertension at baseline. Pulmonary hypertension is a common complication in patients with chronic kidney disease, with a baseline prevalence of 43.5% that increased to 50% at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: